Relative Energy Deficiency in Sport (RED-S): The Female Athlete's Hidden Performance Ceiling

Meet Mara. She is 22 years old, a collegiate distance runner logging 70 miles per week. Her times are improving — until they stop. Then they regress. She stops menstruating, blames stress. Her tibial stress reaction is written off as overtraining. Her resting heart rate climbs. Her VO₂max stalls. She eats "clean," believes she fuels enough, and pushes harder. Over three years she will accrue two bone stress injuries, persistent amenorrhea, a DEXA scan showing bone mineral density in the lowest decile for her age, and a late diagnosis that names what has been happening all along: Relative Energy Deficiency in Sport (RED-S).

Mara is a composite character, but her clinical arc is neither rare nor accidental. The 2023 IOC consensus defines RED-S as "a syndrome of impaired physiological and/or psychological functioning experienced by female and male athletes caused by exposure to problematic — prolonged and/or severe — low energy availability (LEA)" (Mountjoy et al. 2023). In female endurance athletes, RED-S operates as an invisible performance ceiling: the harder the athlete trains without correcting the energy deficit, the more the body dismantles itself to survive. This article defines the syndrome, traces its pathophysiology, provides validated screening criteria, maps its performance costs, and lays out the four-pillar, phase-based recovery protocol that the Victevo Method applies to return-to-sport decisions.

§1 — The Athlete, Painted

Physical Archetype

The female endurance athlete most at risk for RED-S is not necessarily underweight by clinical BMI standards. She is often lean — body fat in the 14–18% range — with a slender frame that carries low absolute fat-free mass relative to training volume. Height is unremarkable (average female distance runner: 163–167 cm, 52–57 kg), but the critical anthropometric marker is fat-free mass (FFM), because energy availability is calculated per kilogram of FFM, not total body weight: EA (kcal/kg FFM/day) = energy intake minus exercise energy expenditure, divided by FFM.

The clinical threshold for problematic LEA in females is below 30 kcal/kg FFM/day (Mountjoy et al. 2023). A 55 kg athlete at 16% body fat carries approximately 46 kg FFM. At 70 miles per week, her exercise energy expenditure may reach 900–1,100 kcal/day. To clear 30 kcal/kg FFM, she must consume at least 2,480 kcal/day above basal needs — a target many endurance athletes miss chronically, often without awareness. Nature selects for a small, efficient body in distance events; culture selects for an even smaller one; the resulting energy mismatch is structural, not incidental.

Movement Archetype

RED-S does not belong to a single sport. It appears wherever the combination of high-volume aerobic training and body-composition pressure coexist: distance running, road and track cycling, cross-country skiing, swimming, rowing, triathlon, gymnastics, dance, and figure skating. In purely endurance-centric sports the movement signature is repetitive, submaximal, and prolonged — large aerobic demand, moderate neuromuscular demand, sustained glycogen dependence. It is precisely this glycogen dependence that creates the metabolic cliff. When LEA reduces liver glycogen stores, the brain's hypothalamic pulsatility of GnRH (gonadotropin-releasing hormone) is suppressed, downstream LH pulsatility collapses, and the endocrine cascade that governs reproductive and skeletal health begins to fail (Cabre et al. 2022).

Performance impairments accumulate along the same axis as aerobic work: VO₂max plateaus or regresses, lactate threshold shifts left, economy degrades as muscle protein synthesis is cannibalized, and HRV — the recovery signal most sensitive to autonomic disruption — deteriorates weeks before an athlete notices anything wrong in a time trial.

Mental Archetype

The female endurance athlete carries a distinct psychological fingerprint. High dispositional achievement motivation, perfectionism, reward from caloric control, identity fusion with sport performance, and elevated anxiety sensitivity are consistently observed in this population. These traits are not pathological in isolation — they are partially responsible for elite performance. But they create risk for RED-S in two ways: they enable the sustained restriction behavior that produces LEA, and they generate resistance to clinical intervention once LEA is diagnosed.

Research on sport-specific perfectionism indicates that maladaptive perfectionism correlates with both disordered eating frequency and recovery adherence in collegiate female athletes (Cabre et al. 2022). Athletes with LEA demonstrate a 2.4-fold increased likelihood of psychological disorders including irritability, depression, impaired judgment, and decreased concentration — effects that further suppress HRV and erode training adaptability. Victevo's 8-Core mental-resilience dimension captures self-regulation under fatigue and decision quality at performance extremes; both markers deteriorate measurably in athletes with chronic LEA before their coaches notice a behavioral shift. Early HRV trending combined with validated questionnaire screening can flag the mental archetype signal up to six weeks before overt clinical presentation.

§2 — The 4 Pillars × Recovery Phases Grid

RED-S recovery does not follow a competition calendar. It follows a physiological timeline governed by four sequential phases:

• Phase 1 — Energy Availability Restoration (weeks 1–6): Energy intake increased by 300–600 kcal/day above current intake; training volume reduced 20–40%.
• Phase 2 — Hormonal Recovery (weeks 6–16+): Eumenorrhea monitored; bone turnover markers re-checked; resistance training prioritized.
• Phase 3 — Training Reintroduction (weeks 12–24): Graduated aerobic re-loading; sport-specific skills re-established.
• Phase 4 — Return to Full Sport (weeks 20–36+): Full training load cleared; 8-Core re-testing confirms readiness.

Duration within each phase is individual. Bone density recovery in particular is measured in months to years, not weeks (von Brackel et al. 2025).

Pillar 1: Strength & Power

Pillar 2: Speed & Agility

Pillar 3: Endurance & Conditioning

Pillar 4: Skill & Sport-IQ

§3 — Diagnostic & Recovery Numbers (3 Tiers)

The following benchmark table applies the Victevo 8-Core framework to female endurance athletes at different diagnostic and recovery stages. RED-S does not define a competitive tier — it defines a physiological state that can occur at any tier. Benchmarks are drawn from the IOC REDs Clinical Assessment Tool Version 2 (CAT2), NCAA Sport Science Institute treatment guidelines, and published RED-S research. Aerobic capacity benchmarks reflect published normative data for female distance runners.

Where exact published normatives for RED-S states are unavailable, cells reflect Victevo editorial targets derived from Mountjoy et al. 2023 CAT2 thresholds, Cabre et al. 2022 clinical data, and von Brackel et al. 2025 bone metabolism findings.

§4 — Medical & Scientific Anchors

1. IOC 2023 Consensus: Redefining RED-S and the CAT2 Tool

Mountjoy et al. (2023) — Br J Sports Med 57(17):1073–1097 — represents the most authoritative and comprehensive update to RED-S science since the syndrome was named in 2014. The 2023 consensus formalizes a new definition: RED-S is a multifactorial syndrome caused by "problematic" LEA — not all LEA, but prolonged or severe exposure that triggers measurable physiological degradation. The update introduces the IOC REDs Clinical Assessment Tool Version 2 (CAT2), a risk-stratification instrument that classifies athletes as low (green), moderate (yellow), or high (red) risk based on accumulated severity across metabolic, endocrine, reproductive, skeletal, cardiovascular, and psychological domains. The CAT2 carries direct training and competition recommendations: green-light athletes may continue full training; yellow-light athletes require a monitored treatment plan; red-light athletes must reduce training load or be withheld from competition. For practitioners applying the Victevo Method, the CAT2 maps directly onto Phase 1–4 readiness gates — no athlete should advance to Phase 3 training reintroduction without at minimum yellow-light clearance on sequential CAT2 assessments.

2. Bone Metabolism in REDs: Catabolic Bone as Performance Risk

von Brackel et al. (2025) — J Cachexia Sarcopenia Muscle — provides the first retrospective evidence that RED-S in athletes is specifically characterized by a catabolic bone metabolism state, with elevated bone resorption markers coexisting with suppressed bone formation. In the study, 24% of elite athletes received a RED-S diagnosis, and stress fractures occurred in 70% of RED-S athletes versus 25% of non-RED-S athletes (p < 0.001). The microstructural deterioration was most pronounced at weight-bearing sites — the tibia, metatarsals, and femoral neck — precisely the locations that determine return-to-sport timelines in endurance athletes. The training implication is decisive: bone marker monitoring (P1NP for formation, CTX for resorption) should be part of every RED-S recovery panel at 8 and 16 weeks, not merely a DEXA at baseline. Normalization of bone formation markers, not only symptom resolution, is a Phase 3 gate.

3. Menstrual Function as a Performance Biomarker

Cabre, Moore, Smith-Ryan, and Hackney (2022) — Deutsche Zeitschrift für Sportmedizin 73:225–234 — synthesizes the clinical and performance implications of RED-S specifically for the female athlete. The paper documents that menstrual dysfunction is the most sensitive early indicator of LEA: luteal phase defects precede frank oligomenorrhea by months, and oligomenorrhea precedes amenorrhea by months more. Each stage along this continuum corresponds to measurable performance losses — a 9.8% decrease in time trial performance in swimmers with LEA versus an 8.2% improvement in energy-replete peers across the same 12-week training program (citing Vanheest et al. data within). The paper also quantifies the psychological interaction: athletes with LEA had 2.4 times increased risk of psychological disorders, and neuromuscular performance was measurably impaired in amenorrheic athletes. For Victevo 8-Core assessments, the HRV and aerobic capacity metrics will flag physiological degradation before an athlete self-reports menstrual changes — making these two metrics an early-warning system requiring no direct questioning about menstrual status.

4. Original RED-S Conceptual Framework: Beyond the Triad

Mountjoy et al. (2014) — Br J Sports Med 48(7):491–497 — established the RED-S model as a deliberate expansion of the female athlete triad, recognizing that LEA's downstream effects extend far beyond the original three endpoints of energy availability, menstrual function, and bone mineral density. The 2014 paper catalogued impairments to metabolic rate, immunity, protein synthesis, cardiovascular health, psychological function, and growth and development. Its lasting contribution to clinical practice was the performance-impact diagram demonstrating that athletes with RED-S experience reduced endurance, impaired coordination and concentration, decreased glycogen stores, decreased muscle strength, and increased injury risk — a constellation that any serious endurance athlete would recognize as catastrophic. The Victevo Method applies this framework as a multi-domain surveillance protocol: no single 8-Core metric tells the RED-S story; it is the pattern of correlated declines across HRV, aerobic capacity, CMJ, and Recovery-Endurance composite that creates the diagnostic signal.

5. NCAA Sport Science Institute: Governing-Body Clinical Protocol

The NCAA Sport Science Institute's Female Athlete Triad Treatment Guidelines — authored by Elizabeth Joy, MD, MPH, FACSM, and referenced in NCAA health and safety policy — establish a multidisciplinary team (MDT) as the required care model: sports medicine physician, registered dietitian specializing in sport nutrition, and mental health professional as the minimum core. The NCAA protocol specifies that a 5–10% body weight gain, or 1–4 kg, is associated with resumption of menses in most amenorrheic athletes, and that energy intake targets should begin with a 20–30% caloric increase over baseline needs. The guidelines explicitly caution that oral contraceptive pills do not restore spontaneous menses, do not normalize the metabolic impairments to bone health, and should not substitute for energy availability restoration. The Victevo Method aligns with this governing-body framework: Phase 1 always begins with caloric rehabilitation, never hormonal intervention as a primary tool.

§5 — The Gap, Measured

Mara's diagnosis was delayed by three years. Not because the signs were absent, but because no one was measuring the right things in the right sequence. Her times declined by 4% over two competitive seasons — inside the normal variance coaches attribute to training cycles. Her HRV dropped 18 RMSSD points — a signal that her wearable logged daily but that nobody reviewed in aggregate. Her CMJ declined 3 cm — below the threshold that would have triggered a force plate investigation. Her menses stopped — reported once to her athletic trainer, documented as "stress-related," and not connected to the performance and recovery data already in the system.

The Victevo Method applies to RED-S in exactly the sequence it applies to every physical gap:

1. Measure — EA, HRV trend, CMJ, aerobic capacity (VO₂max and threshold), bone marker panel, menstrual status, and CAT2 risk score. Do not measure one marker in isolation.
2. Compare — to tier norms (D1 female endurance average), to her own 90-day baseline, and to published CAT2 thresholds.
3. Identify the gap — quantify the EA deficit in kcal/kg FFM/day; name the specific delta in HRV, CMJ, and aerobic threshold relative to her functional baseline.
4. Build the plan — phase the recovery across the four pillars above. Do not compress Phases 1 and 2 to satisfy a competition calendar.
5. Use real equipment — force plate, calibrated VO₂ protocol, DEXA, bone marker blood panel. Subjective coach assessment alone is insufficient for RED-S clearance.
6. Re-measure and prove — 8-Core re-assessment at Phase 2 completion and again at Phase 4 clearance. HRV trending reviewed weekly. Bone marker panel at 8 and 16 weeks.

Mara's recovery arc, when it finally begins, takes fourteen months to reach full return-to-sport clearance. Her VO₂max regains the ground it lost. Her CMJ exceeds her pre-diagnosis baseline. Her menses return at month six. Her next two competitive seasons are the best of her career.

The performance ceiling is not physiological. It is informational. Measure the right things, close the gap, and the ceiling disappears.

See the Victevo Method → | See the 8-Core →

Sources

1. Mountjoy M, Ackerman KE, Bailey DM, Burke LM, Constantini N, Hackney AC, et al. 2023 International Olympic Committee's (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). Br J Sports Med. 2023;57(17):1073–1097. doi:10.1136/bjsports-2023-106994. PMID: 37752011. https://pubmed.ncbi.nlm.nih.gov/37752011/

2. von Brackel FN, Munzinger R, Bartosik M, Simon A, Barvencik F, Oheim R, Amling M. Impact of Relative Energy Deficiency in Sport (REDs) on Bone Health in Elite Athletes: A Retrospective Analysis. J Cachexia Sarcopenia Muscle. 2025. doi:10.1002/jcsm.70082. PMID: 41030229. https://pubmed.ncbi.nlm.nih.gov/41030229/

3. Cabre HE, Moore SR, Smith-Ryan AE, Hackney AC. Relative Energy Deficiency in Sport (RED-S): Scientific, Clinical, and Practical Implications for the Female Athlete. Dtsch Z Sportmed. 2022;73:225–234. doi:10.5960/dzsm.2022.546. PMID: 36479178. https://pubmed.ncbi.nlm.nih.gov/36479178/

4. Mountjoy M, Sundgot-Borgen J, Burke L, Carter S, Constantini N, Lebrun C, et al. The IOC consensus statement: beyond the Female Athlete Triad — Relative Energy Deficiency in Sport (RED-S). Br J Sports Med. 2014;48(7):491–497. doi:10.1136/bjsports-2014-093502. PMID: 24620037. https://pubmed.ncbi.nlm.nih.gov/24620037/

5. Joy E. Treatment of the Female Athlete Triad. NCAA Sport Science Institute; 2014. https://www.ncaa.org/sports/2014/5/14/treatment-of-the-female-athlete-triad.aspx?path=ssi

6. IOC REDs Clinical Assessment Tool Version 2 (CAT2). International Olympic Committee; 2023. https://bjsm.bmj.com/content/57/17/1073

© 2026 Victevo Media, LLC. All rights reserved. Built on the Victevo Method.™